Sign In

Login

Password

Forgot Password ? Sign Up

Merestinib (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Merestinib" in English language version.

refsWebsite
Global rank English rank
2nih.gov
4th place
4th place
1doi.org
2nd place
2nd place
1clinicaltrials.gov
5,225th place
4,062nd place
1springer.com
274th place
309th place

clinicaltrials.gov (Global: 5,225th place; English: 4,062nd place)

  • Clinical trial number NCT02711553 for "A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer" at ClinicalTrials.gov

doi.org (Global: 2nd place; English: 2nd place)

  • Konicek BW, Capen AR, Credille KM, Ebert PJ, Falcon BL, Heady GL, et al. (March 2018). "Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors". Oncotarget. 9 (17): 13796–13806. doi:10.18632/oncotarget.24488. PMC 5862616. PMID 29568395.

nih.gov (Global: 4th place; English: 4th place)

ncbi.nlm.nih.gov

  • Konicek BW, Capen AR, Credille KM, Ebert PJ, Falcon BL, Heady GL, et al. (March 2018). "Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors". Oncotarget. 9 (17): 13796–13806. doi:10.18632/oncotarget.24488. PMC 5862616. PMID 29568395.

pubmed.ncbi.nlm.nih.gov

  • Konicek BW, Capen AR, Credille KM, Ebert PJ, Falcon BL, Heady GL, et al. (March 2018). "Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors". Oncotarget. 9 (17): 13796–13806. doi:10.18632/oncotarget.24488. PMC 5862616. PMID 29568395.

springer.com (Global: 274th place; English: 309th place)

adisinsight.springer.com